Preserving macrolides
28 August 2020
In line with other antibiotics, macrolide prescribing in primary care in England has decreased over the past 5 years, falling by 17.3% from 4.2 milllion items in 2015/2016 to 3.5 million items in 2019/2020. Macrolide resistance in Gram-positive infections is increasing, largely because of an increasing incidence of infections. Higher numbers of resistant infections are seen in older age groups.
Further reading: The Pharmaceutical Journal
Author(s): Dawn Connelly, Priya N Chudasama
Effective Surveillance Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support kindly provided by
 |
Antimicrobial Resistance Fighter Coalition |
 |
CDD VAULT Complexity Simplified |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
